Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $2 | $34 | $34 |
| - Cash | $11 | $8 | $11 | $11 |
| + Debt | $6 | $6 | $10 | $11 |
| Enterprise Value | -$1 | $0 | $34 | $34 |
| Revenue | $4 | $4 | $5 | $22 |
| % Growth | -4.8% | -20% | -75.3% | – |
| Gross Profit | $3 | $2 | $4 | $15 |
| % Margin | 69.3% | 44.4% | 68% | 66.9% |
| EBITDA | -$1 | -$2 | -$1 | -$15 |
| % Margin | -27.1% | -43.4% | -22.9% | -66.8% |
| Net Income | -$7 | -$3 | -$3 | -$8 |
| % Margin | -177.3% | -77% | -49.5% | -36.2% |
| EPS Diluted | -4.87 | -19.69 | -0.23 | -0.68 |
| % Growth | 75.3% | -8,460.9% | 66.2% | – |
| Operating Cash Flow | -$1 | -$1 | -$0 | -$4 |
| Capital Expenditures | $2 | $0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$1 | -$1 | -$4 |